The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

JM Peters, YM Shah, FJ Gonzalez - Nature Reviews Cancer, 2012 - nature.com
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors that are involved in regulating glucose and lipid homeostasis, inflammation …

Apoptosis-inducing effects of amaryllidaceae alkaloids

J J. Nair, J van Staden, J Bastida - Current medicinal chemistry, 2016 - benthamdirect.com
The Amaryllidaceae occupies a privileged status amongst medicinal plants in having
delivered the Alzheimer's drug galanthamine to the clinical market. Following its resounding …

Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids

AD Southam, FL Khanim, RE Hayden, JK Constantinou… - Cancer research, 2015 - AACR
The redeployed drug combination of bezafibrate and medroxyprogesterone acetate
(designated BaP) has potent in vivo anticancer activity in acute myelogenous leukemia …

Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks

M Masoodi, M Eiden, A Koulman, D Spaner… - Analytical …, 2010 - ACS Publications
In the present work we describe the development of an analytical technique for
simultaneous profiling of over 100 biochemically related lipid mediators in biological …

Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia

FL Khanim, RE Hayden, J Birtwistle, A Lodi, S Tiziani… - PLoS …, 2009 - journals.plos.org
Background The majority of acute myeloid leukaemia (AML) patients are over sixty years of
age. With current treatment regimens, survival rates amongst these, and also those younger …

[HTML][HTML] Acute and chronic saturated fatty acid treatment as a key instigator of the TLR-mediated inflammatory response in human adipose tissue, in vitro

EM Youssef-Elabd, KC McGee, G Tripathi… - The Journal of nutritional …, 2012 - Elsevier
A post-prandial increase in saturated fatty acids (SFAs) and glucose (Glc) activates an
inflammatory response, which may be prolonged following restoration of physiological SFAs …

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

P Veliça, NJ Davies, PP Rocha, H Schrewe, JP Ride… - Molecular cancer, 2009 - Springer
Background Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily
have been implicated in the progression of prostate, breast, endometrial and leukemic …

Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile

E Novotná, N Büküm, J Hofman, M Flaxová… - Archives of …, 2018 - Springer
Dinaciclib is a multi-specific cyclin-dependent kinase (CDK) inhibitor with significant
preclinical and clinical activity. It inhibits CDK1, CDK2, CDK5, CDK9 and CDK12 in the …

Repair of oxidative DNA damage is delayed in the Ser326Cys polymorphic variant of the base excision repair protein OGG1

RM Kershaw, NJ Hodges - Mutagenesis, 2012 - academic.oup.com
Gene–environment interactions influence an individual's risk of disease development. A
common human 8-oxoguanine DNA glycosylase 1 (OGG1) variant, Cys326-hOGG1, has …

Retinaldehyde is a substrate for human aldo–keto reductases of the 1C subfamily

FX Ruiz, S Porté, O Gallego, A Moro… - Biochemical …, 2011 - portlandpress.com
Human AKR (aldo–keto reductase) 1C proteins (AKR1C1–AKR1C4) exhibit relevant activity
with steroids, regulating hormone signalling at the pre-receptor level. In the present study …